Recent experiments by US researchers using artificial intelligence to design novel viruses to combat bacteria like E. coli have intensified debates over biosecurity and the regulation of AI-driven biological weapons, according to policy analyses from the Center for European Policy Analysis. While these computational tools help map protein structures and invent medical therapies, defense analysts warn they also lower technical hurdles for malicious actors.
The Challenge of Securing Formal Agreements on AI
According to James Lewis, a distinguished fellow on the tech policy program at the Center for European Policy Analysis, the United States has grown unaccustomed to negotiating formal treaties during its unipolar moment. Establishing international guardrails requires a shared perception of risk, mirroring how the Cuban Missile Crisis inspired a generation of arms control agreements because leaders vividly remembered the destruction of World War II. Without that common understanding, negotiations stall.
Furthermore, major nuclear powers hold sharply divergent views. Russian thinking on AI risk remains unclear, while China believes it can manage the dangers of weaponization without pausing domestic technological development, according to policy research. Unilateral export controls cannot replace formal diplomatic engagement, and technical guardrails ultimately require political consent from all participating nations.
Lessons From Historical Arms Control and the 1972 Biological Weapons Convention
Managing biosecurity risks means evaluating how emerging machine learning models interact with longstanding frameworks like the 1972 Biological Weapons Convention, which already restricts the development and stockpiling of biological agents. Controlling biological weapons has always proved difficult because dual-use manufacturing equipment, such as commercial brewery machinery, can easily be repurposed, according to historical policy reviews.
Did you know?
Biological weapons have historically proven easy to manufacture but difficult to deploy effectively due to severe operational constraints and unpredictable contagion risks that threaten attackers just as much as targets, according to policy research from the Center for European Policy Analysis.
Historical precedents highlight the friction of verification. In one extreme instance cited by the Center for European Policy Analysis, the United States inadvertently bombed a pharmaceutical plant in Sudan after satellite imagery and nearby soil samples falsely indicated involvement in biological weapons production. Operational realities dictate that while stockpiles have occasionally been assembled—notably by Russia—actual deployment remains exceedingly rare outside of isolated historical incidents like salad bar and subway car contaminations.
Narrow High-Level Engagement as the Path Forward
Expanding negotiations too widely dilutes focus and prevents binding consensus. According to policy analysis, the United Nations is ill-suited to initiate these talks due to its diffuse membership, and Davos-style forums risk turning critical security negotiations into academic seminars. Any viable framework requires direct presidential-level commitments from the primary nuclear-armed states—specifically the United States, China, and Russia—to ban research that employs artificial intelligence for advanced biological weapons.
| Approach | Requirements | Current Status |
|---|---|---|
| Political Commitment | Presidential buy-in from US, China, and Russia | Unlikely given current geopolitical priorities |
| Specific Thresholds | Durable performance and payload specifications | Impeded by an incomplete understanding of AI capabilities |
Frequently Asked Questions
Are international agreements specifically for artificial intelligence currently possible?
No. According to policy analysis from the Center for European Policy Analysis, calls for standalone international AI agreements are premature because major powers lack consensus, verification is exceptionally difficult, and existing non-proliferation treaties can be amended instead.
Why are biological weapons difficult to regulate?
Biological agents suffer from severe dual-use applications. Equipment utilized in legitimate industries like commercial brewing can also manufacture biological pathogens, making remote verification nearly impossible without direct state consent.
What role does China play in potential AI arms control?
China has expressed concern regarding the weaponization of artificial intelligence but maintains that risks can be managed internally without halting technological development. Analysts note that China may only enter negotiations if it believes thresholds will constrain adversaries while protecting its own progress.
Related reading